Pfizer Taps Harvard's Ole Isacson as CSO of Neuroscience Research Unit

Pfizer has announced that Dr. Ole Isacson will become its Chief Scientific Officer of the Neuroscience Research Unit and Senior Vice President, effective September 16. 

Dr. Isacson is a Professor of Neurology at Harvard Medical School, and will continue to serve in an educational role. He is also a founding director of the Neuroregeneration Institute at McLean Hospital. 

Dr. Isacson will report directly to Mikael Dolsten, President of Worldwide Research and Development.